An in-depth comparative study exclusively focusing on the role of FKBP38 in the hypoxic and normoxic conditions in glioblastoma would decipher if targeting FKBP38 has a differential outcome, based on the normoxic and hypoxic statuses of the glioblastoma tumor cells. This evidence concerns the gene FKBP8 and neoplasm.